We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$342M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$83.1M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$43.8M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$40.2M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$26.6M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SSBK
3726
DELISTED
Southern States Bancshares
SSBK
$20K ﹤0.01%
+1,072
New +$20.9K
TCMD icon
3727
Tactile Systems Technology
TCMD
$555M
$20K ﹤0.01%
451
-167
-27% -$7.51K
VT icon
3728
Vanguard Total World Stock ETF
VT
$81.9B
$20K ﹤0.01%
+200
New +$21K
VWO icon
3729
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$20K ﹤0.01%
400
-1,328
-77% -$68.6K
WTBA icon
3730
West Bancorporation
WTBA
$511M
$20K ﹤0.01%
695
-2,926
-81% -$85.8K
XENE icon
3731
Xenon Pharmaceuticals
XENE
$6.31B
$20K ﹤0.01%
1,313
+924
+238% +$16.1K
SPRB
3732
Spruce Biosciences
SPRB
$135M
$20K ﹤0.01%
43
+31
+258% +$19.5K
CVII
3733
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$20K ﹤0.01%
+2,097
New +$20.4K
SWSSU
3734
DELISTED
Clean Energy Special Situations Corp. Unit
SWSSU
$20K ﹤0.01%
+4,072
New +$20.2K
OXUSU
3735
DELISTED
Oxus Acquisition Corp. Unit
OXUSU
$20K ﹤0.01%
+1,923
New +$19.4K
TBLT
3736
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$20K ﹤0.01%
4
+3
+300% +$17.5K
SIOX
3737
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$20K ﹤0.01%
9,262
+9,161
+9,070% +$19.9K
BTAQ
3738
DELISTED
Burgundy Technology Acquisition Corporation Class A Ordinary shares
BTAQ
$20K ﹤0.01%
2,068
+1,815
+717% +$17.9K
CSLT
3739
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$20K ﹤0.01%
12,590
+8,467
+205% +$16.6K
GDP
3740
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$20K ﹤0.01%
840
+769
+1,083% +$13.5K
XONE
3741
DELISTED
The ExOne Company
XONE
$20K ﹤0.01%
858
-3,222
-79% -$67.6K
AVEO
3742
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$20K ﹤0.01%
3,135
-25,629
-89% -$153K
EBIX
3743
DELISTED
Ebix Inc
EBIX
$20K ﹤0.01%
761
-939
-55% -$27.5K
ACRE
3744
Ares Commercial Real Estate
ACRE
$261M
$19K ﹤0.01%
1,241
-3,846
-76% -$58.4K
BRSP
3745
BrightSpire Capital
BRSP
$628M
$19K ﹤0.01%
2,016
-1,004
-33% -$9.7K
BTU icon
3746
Peabody Energy
BTU
$3.01B
$19K ﹤0.01%
1,274
-6,313
-83% -$82.7K
CLBK icon
3747
Columbia Financial
CLBK
$1.21B
$19K ﹤0.01%
1,043
-407
-28% -$7.28K
COE
3748
51Talk Online Education Group
COE
$121M
$19K ﹤0.01%
1,799
+1,108
+160% +$17K
CPNG icon
3749
Coupang
CPNG
$29.3B
$19K ﹤0.01%
700
-474
-40% -$16.4K
CTXR icon
3750
Citius Pharmaceuticals
CTXR
$21M
$19K ﹤0.01%
375
-29
-7% -$1.46K
148 149
150
151 152

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.